The Board proposes that the EGM:

-               Decides to reduce the share capital of the Company with 4.224.789,60 kronor, without reducing the number of shares. Thereby, the share capital of the Company will be reduced to 12.674.368,80 kronor and the quota value of the share to 0,6 kronor.

The reason for the proposal is to align the quota value to the terms and conditions of the financing agreement that was entered with European High Growth Opportunities Securitization Fund through its advisor Alpha Blue Ocean (for more information, please refer to the press release of 21 June 2018).

-               Decides on a rights issue of 6.2 MSEK, comprising Units that if fully subscribed brings circa 6,2 MSEK before issuance costs.

Summary:

• The one who is a registered shareholder on 23 November 2018 in QuickCool has preferential rights to Units in this Rights Issue, where every existing share entitles to one (1) Unit Right (UR) and ten (10) URs entitle to subscribe to one (1) Unit at a subscription rate of 3,00 SEK per Unit.
• One Unit comprises three (3) shares and one (1) warrant TO2.  
• The subscription period starts on 27 November and ends on 11 December 2018.
• The rights issue is guaranteed through guarantee commitments to about 50% of the rights issue, amounting to circa 3 MSEK.
• The rights issue will primarily be used to improve the financial flexibility in conjunction with the production of the 0-series and the third party testing.  
• The terms and conditions of the rights issue are aligned with the terms and conditions that were agreed with European High Growth Opportunities Securitization Fund. 

 Indicative Timeplan  

The Board of Directors’ proposal will be presented and decided upon at the Extraordinary General Meeting on 15 November 2018. The EGM is called for in a separate press release today.

Lund, 17 October 2018
QuickCool AB (publ)
Board of Directors

Fredrik Radencrantz
CEO

QuickCool AB 
Ideon Science Park
Beta 6, Scheelevägen 17 - SE-223 70 Lund - Sweden
E-mail: fredrik.radencrantz@quickcool.se Web: www.quickcool.se
Mobile +46 (0)73 834 1188

This information is such that QuickCool AB is required to make public in accordance with the EU’s market abuse regulation (MAR) and the Swedish Securities Market Act. The information was made publicly available by the Company’s contact person on 17 October, 2018.

Quickcool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the Quickcool SYSTEM. Quickcool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. Quickcool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to www.quickcool.se